Omeprazol Sandoz (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Sandoz, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Sandoz is a proton pump inhibitor that acts on the gastric acid secretion pathway.

- Gastro‑esophageal reflux disease (GERD): Provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: Facilitates ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: Controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens: Used as an adjunctive agent to improve eradication rates when combined with antibiotics. - NSAID‑induced ulcer prophylaxis: Lowers the risk of ulcer development in patients requiring chronic NSAID therapy.

Omeprazol Sandoz may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: Mild to moderate intensity. - Diarrhea: Usually transient and self‑limiting. - Nausea: May occur shortly after dosing. - Abdominal pain: Cramp‑like discomfort. - Flatulence: Excess gas production. - Constipation: Reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: Severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: Inflammation of kidney interstitium causing renal impairment. - Osteoporosis‑related fractures: Increased risk of hip, wrist or vertebral fractures with long‑term use. - Hypomagnesemia: Low serum magnesium leading to muscle cramps or cardiac arrhythmias. - Severe cutaneous adverse reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: Rare systemic allergic reaction requiring immediate medical attention.

Before starting Omeprazol Sandoz, consider the following safety measures:

- Assess renal function: Adjust use in severe renal impairment. - Evaluate hepatic function: Use with caution in moderate to severe liver disease. - Review long‑term therapy: Limit duration to the shortest effective period to reduce fracture risk. - Monitor for infections: Be alert to symptoms of gastrointestinal infections, especially C. difficile. - Pregnancy and lactation: Use only if the potential benefit justifies the potential risk. - Store at ambient temperature: Keep below 25°C in the original container, protected from moisture and direct sunlight.

Omeprazol Sandoz can affect the plasma concentrations of several co‑administered medicines. Proper monitoring and dose adjustments are recommended.

Major Interactions (Avoid): - Clopidogrel: Reduced antiplatelet effect, increasing cardiovascular event risk. - Atazanavir: Decreased antiviral exposure, compromising HIV treatment efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: Potential increase in INR, requiring more frequent coagulation monitoring. - Digoxin: May raise serum digoxin levels, necessitating dosage review. - Methotrexate (high dose): Can increase toxicity; monitor renal function and drug levels. - Mycophenolate mofetil: Reduced absorption, possibly diminishing immunosuppressive effect. - Iron supplements: Decreased iron absorption; separate dosing times by at least 2 hours.